CN Patent

CN114805438A — 含磷酰基的tyk2抑制剂化合物

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2022-07-29 · 4y expired

What this patent protects

本申请属于药物化学领域，提供了一种含磷酰基的TYK2抑制剂化合物及其制备方法，并涉及其在制备治疗TYK2相关疾病的药物中的用途。

USPTO Abstract

本申请属于药物化学领域，提供了一种含磷酰基的TYK2抑制剂化合物及其制备方法，并涉及其在制备治疗TYK2相关疾病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114805438A
Jurisdiction
CN
Classification
—
Expires
2022-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.